Keyphrases
Apoptosis
100%
Cyclin-dependent Kinase 4 (CDK4)
93%
Multikinase Inhibitor
59%
Tyrosine Kinase
57%
Imatinib
55%
BCR-ABL
55%
Myeloproliferative Neoplasms
51%
Rigosertib
49%
Kinase Inhibitor
49%
Myeloid Cells
49%
Small Molecules
49%
Chronic Myeloid Leukemia
45%
Alternative Splicing
40%
C-Myb
37%
Mantle Cell Lymphoma
37%
Life-and-death
37%
Death Domain
37%
TNF Receptor 1 (TNFR1)
37%
Non-ATP Competitive
37%
Neuronal Differentiation
37%
Signaling Pathway
36%
Transcription Factor
35%
IL-3
34%
Tumor Cells
34%
Imatinib Resistance
32%
Precursor Cells
28%
Targeted Therapy
27%
STI571
27%
Gleevec
27%
Cell Transformation
27%
Activators of Transcription Pathway
27%
TRAF Domain
27%
TRADD
27%
Janus Kinase-signal Transducer
27%
Ligand-binding Domain
27%
Cell Development
27%
Hematopoiesis
27%
Cell Proliferation
26%
Potent Inhibitor
25%
Plasma Membrane
24%
Novel Genes
23%
Signal Transducer
23%
Hematopoietic Cytokines
23%
Cytokine Receptor Signaling
23%
Transcriptional Repressor
23%
Kinase Domain
22%
Philadelphia Chromosome
22%
Dual Inhibition
22%
Small Molecule Inhibitors
22%
Myeloid Progenitors
22%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
79%
Malignant Neoplasm
76%
Rigosertib
74%
Disease
73%
Imatinib
65%
Adenosine Triphosphate
59%
Phosphotransferase Inhibitor
50%
Phosphotransferase
46%
Mantle Cell Lymphoma
37%
Janus Kinase 1
37%
Myeloproliferative Disorder
31%
Cycline
31%
Cytokine
30%
Chronic Myeloid Leukemia
29%
Competitive Inhibitor
25%
Protein Tyrosine Kinase
24%
Cytokine Receptor
24%
Janus Kinase
24%
Cyclin Dependent Kinase 4
21%
Leukemia
19%
Protein Tyrosine Kinase Inhibitor
18%
Casein Kinase II
18%
Cyanide
18%
Tumor Necrosis Factor
18%
Retinoblastoma
18%
Acute Lymphoblastic Leukemia
18%
Chemotherapy
18%
Lethality
18%
Piperazine
18%
Triple Negative Breast Cancer
18%
Tubulin
18%
Anticarcinogen
18%
Cancer Growth Factor
18%
Receptor
18%
Carcinogenesis
15%
Cyclin Dependent Kinase
15%
Mouse Mutant
15%
Serine
15%
Transcription Factors
15%
Threonine
15%
Myelodysplastic Syndrome
13%
Palbociclib
12%
Sulfone
11%
Mouse Model
9%
Structure Activity Relationship
9%
Trastuzumab
9%
Oncoprotein
9%
Philadelphia 1 Chromosome
9%
Blood Toxicity
9%
Binding Site
9%
Biochemistry, Genetics and Molecular Biology
Kinase
59%
Phosphotransferase
59%
Small Molecule
43%
Adenosine Triphosphate
43%
Myeloid
37%
Tumor Necrosis Factor Receptor
37%
Tumor Necrosis Factor
37%
Signal Transduction
37%
Cell Death
30%
Cell Cycle
29%
Imatinib
27%
Cell Transformation
24%
Transcription Factors
24%
Binding Domain
24%
Hematopoiesis
24%
Competitive Inhibition
24%
Protein Family
20%
Tnf Receptor Associated Death Domain
18%
N-Myc
18%
Myristoylation
18%
Transcription
18%
Cytokine Receptor
18%
Janus Kinase
18%
Kinase A
18%
Cellular Differentiation
18%
Tubulin
18%
Membrane Binding
18%
Osteoclastogenesis
18%
T Cell
18%
Cancer Stem Cell
18%
B Cell
18%
Casein Kinase 2
18%
Targeting Protein
18%
Transcription Factor PAX5
18%
Macrophage
18%
Mitosis Inhibition
18%
Tyrosine Kinase
18%
Retinoblastoma
18%
Death Domain
18%
Receptor Tyrosine Kinase
18%
Anticancer
18%
PI3K/AKT/mTOR Pathway
18%
FADD
18%
Cancer Growth Factor
18%
Cyclin-Dependent Kinase
18%
Oncogene
17%
Precursor
16%
Cell Proliferation
15%
Cell Membrane
15%
Apoptosis
14%